相关实验视频

Updated: Jun 16, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

设计,合成,对接研究和生物活性评价1,2,3-三醇尤根醇衍生物的1,2,3-三醇尤根醇衍生物

Thiago Antonio de Sousa Cutrim¹, Fernando Fontes Barcelos², Leandra Martins Meireles¹

¹Universidade de Vila Velha, Departamento de Farmácia, Programa de Pós-Graduação em Ciências Farmacêuticas, Av. Comissário José Dantas de Melo, 21, Vila Velha, Espírito Santo State, 29102-770, Brazil.

Future medicinal chemistry

|August 19, 2024

概括

新的基于eugenol (EUG) 的三醇衍生物对Trichophyton rubrum具有强烈的抗真菌活性,这是皮肤感染的原因. 化合物2a特别有效,这表明它可能是对皮肤植物病的有前途的新疗法.

科学领域:

药用化学医学化学
有机合成有机合成
药理学药理学是指药理学的学科.

背景情况:

皮肤植物病是一种常见的真菌感染,由Trichophyton rubrum引起.
欧原醇 (EUG) 是一种具有潜在治疗性能的天然化合物.
需要新的抗真菌剂来对抗耐药性真菌菌株.

研究的目的:

设计和合成新型1,2,3-二醇衍生物,其中包括欧原醇 (EUG).
评估这些新化合物的体外抗真菌和细胞毒性.
研究这些衍生品作为治疗皮肤植物病的治疗剂的潜力.

主要方法:

合成含有欧原醇的1,2,3-三衍生物.
分子对接研究,以预测结合相互作用.
在体外对Trichophyton rubrum进行抗真菌活性测试.
药物动力学概况的预测.

主要成果:

已经成功合成了几种新的EUG-triazole衍生物.
化合物2a和2i对Trichophyton rubrum表现出强大的抗真菌活性.
化合物2a的强度是eugenol (EUG) 的四倍.
分子对接建议在兰醇-14-α-脱甲基酶位点与伊特拉科纳相似的结合.
预计口服时有利的药理动力学特性.

结论:

化合物2a是治疗皮肤植物病的一个非常有前途的抗真菌候选物.
基于EUG的三醇衍生物代表了一类有价值的化合物,用于抗真菌药物的发现.
对化合物2a进行进一步的研究是为其临床开发的必要.

关键词:

三科菲顿 (Trichophyton) 是一个三科菲顿.抗真菌活动的抗真菌活性.皮肤细胞 (dermatophytes) 是一种植物.欧根醇是一种三醇化合物三醇化合物

更多相关视频

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

相关概念视频

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...